{"id":43980,"date":"2022-05-17T11:01:31","date_gmt":"2022-05-17T09:01:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-breast-imaging-devices-market-growth-forecasts-report-2022-featuring-siemens-healthcare-ge-healthcare-hologic-and-aurora-imaging-technology-researchandmarkets-com\/"},"modified":"2022-05-17T11:01:31","modified_gmt":"2022-05-17T09:01:31","slug":"global-breast-imaging-devices-market-growth-forecasts-report-2022-featuring-siemens-healthcare-ge-healthcare-hologic-and-aurora-imaging-technology-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-breast-imaging-devices-market-growth-forecasts-report-2022-featuring-siemens-healthcare-ge-healthcare-hologic-and-aurora-imaging-technology-researchandmarkets-com\/","title":{"rendered":"Global Breast Imaging Devices Market Growth Forecasts Report 2022, Featuring Siemens Healthcare, GE Healthcare, Hologic and Aurora Imaging Technology – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Breast Imaging Devices Market Report 2022”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global breast imaging devices market is expected to grow from $4.06 billion in 2021 to $4.31 billion in 2022 at a compound annual growth rate (CAGR) of 6.3%. The market is expected to grow to $5.27 billion in 2026 at a CAGR of 5.2%.\n<\/p>\n

\nNorth America was the largest region in the breast imaging devices market in 2021. Asia Pacific was the second largest market in breast imaging devices market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.\n<\/p>\n

\nThe rising prevalence of breast cancer is anticipated to contribute to the breast imaging devices market’s growth. A growing number of hormone replacement therapy (HRT), hormonal imbalances, menopause, and various reproductive disorders have significantly increased the risks of breast cancer. According to the World Health Organization (WHO), breast cancer is the most common cancer in women, impacting 2.1 million women annually. Breast cancer causes the highest number of cancer-related deaths among women. For instance, in 2020, according to the American Institute of cancer research, there were an estimated 18.1 million cancer cases around the world. It was estimated that 9.3 million cases were in men and 8.8 million in women. Among them, lung and breast cancers are the most common cancers in the world, and about 12.5% and 12.2% of the new cases are diagnosed in 2020.\n<\/p>\n

\nThe high cost associated with breast imaging devices is expected to limit the growth of the market shortly. The cost of digital mammography systems varies for different models and companies. For instance, the cost of the 2D model’s mammography systems ranges between $65,000 to $95,000 for GE Healthcare and Hologic, Inc products. Whereas 3D models of the same company range between $90,000 to $200,000. In addition to this, the premium 3D models of GE Healthcare and Hologic Inc. are priced between $1,40,000 to $2,75,000. Therefore, the high cost of breast imaging systems is a major concern for end-users, which is predicted to hinder the growth of the breast imaging devices market over the forecast period.\n<\/p>\n

\nMajor players operating in the breast imaging devices market are undertaking various strategic initiatives such as the launch of technologically advanced or innovative products and product portfolio expansion, which is likely to be a leading trend in the breast imaging market. Various companies are introducing new advanced devices in the market to attract a large customer base and maintain their position in the competitive business environment.\n<\/p>\n

\nThe report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider breast imaging devices market, and compares it with other markets.\n<\/p>\n